Habitual daytime napping is a significant aspect of many older adults’ sleep-wake cycle. Growing evidence links napping and cognition in the context of Alzheimer's disease (AD), yet little is known about how genetic risk influences this relationship.
Objective
This study investigates interactions between genetic risk for AD and napping on cognition in 1655 cognitively healthy middle-aged to older adults.
Methods
Cognition was assessed using a self-administered online battery and reduced to three variables: memory, visuospatial abilities and executive functions. Genetic risk was assessed with the presence of APOE ɛ4 allele and polygenic risk scores for AD (PRS; excluding APOE). ANCOVA assessed interactions.
Results
There was a significant interaction between APOE ɛ4 and napping duration on the memory component (F(2,1645) = 3.84, p = 0.022, ηp2 = 0.005). APOE ɛ4 carriers reporting long naps demonstrated better memory than non-carriers also reporting long naps. Among APOE ɛ4 carriers, those who napped for ≥ 1 h performed better than those reporting shorter naps. In a separate analysis, there was a significant interaction between PRS and napping (F(2653) = 3.44, p = 0.033, ηp2 = 0.010). Low PRS was related to better memory than high PRS among those who did not nap. Within the low PRS group, participants who did not nap outperformed those reporting short naps. Results remained significant after accounting for overnight sleep efficiency.
Conclusions
Findings suggest that the relationship between napping and memory may vary as a function of genetic risk for AD. Results could inform studies looking into personalized preventative treatment based on genetic profiles.
LiXFengXSunX, et al.Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019. Front Aging Neurosci2022; 14: 937486.
2.
HebertLEWeuveJScherrPA, et al.Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology2013; 80: 1778–1783.
3.
van der FlierWMde VugtMESmetsEMA, et al.Towards a future where Alzheimer’s disease pathology is stopped before the onset of dementia. Nature Aging2023; 3: 494–505.
4.
JackCRJrKnopmanDSJagustWJ, et al.Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol2010; 9: 119–128.
5.
LivingstonGHuntleyJLiuKY, et al.Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet2024; 404: 572–628.
6.
BellenguezCKüçükaliFJansenIE, et al.New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet2022; 54: 412–436.
7.
WangYYGeYJTanCC, et al.The proportion of APOE4 carriers among non-demented individuals: a pooled analysis of 389,000 community-dwellers. J Alzheimers Dis2021; 81: 1331–1339.
8.
ForteaJPeguerolesJAlcoleaD, et al.APOE4 Homozygosity represents a distinct genetic form of Alzheimer’s disease. Nat Med2024; 30: 1284–1291.
9.
TroutwineBRHamidLLysakerCR, et al.Apolipoprotein E and Alzheimer's disease. Acta Pharm Sin B2022; 12: 496–510.
10.
WisdomNMCallahanJLHawkinsKA. The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol Aging2011; 32: 63–74.
11.
Gharbi-MelianiADugravotASabiaS, et al.The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20years follow-up of the whitehall II study. Alzheimers Res Ther2021; 13: 5.
12.
ClarkKLeungYYLeeWP, et al.Polygenic risk scores in Alzheimer's disease genetics: methodology, applications, inclusion, and diversity. J Alzheimers Dis2022; 89: 1–12.
13.
KauppiKRönnlundMNordin AdolfssonA, et al.Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging. Transl Psychiatry2020; 10: 250.
14.
HarrisSEDaviesGLucianoM, et al.Polygenic risk for Alzheimer's disease is not associated with cognitive ability or cognitive aging in non-demented older people. J Alzheimers Dis2014; 39: 565–574.
15.
O'DonoghueMCMurphySEZamboniG, et al.APOE Genotype and cognition in healthy individuals at risk of Alzheimer's disease: a review. Cortex2018; 104: 103–123.
16.
BubuOMBrannickMMortimerJ, et al.Sleep, cognitive impairment, and Alzheimer’s disease: a systematic review and meta-analysis. Sleep2016; 40: zsw032.
17.
CasagrandeMForteGFavieriF, et al.Sleep quality and aging: a systematic review on healthy older people, mild cognitive impairment and Alzheimer's disease. Int J Environ Res Public Health2022; 19: 8457.
18.
SabiaSFayosseADumurgierJ, et al.Association of sleep duration in middle and old age with incidence of dementia. Nat Commun2021; 12: 2289.
19.
BrownBMRainey-SmithSRVillemagneVL, et al.The relationship between sleep quality and brain amyloid burden. Sleep2016; 39: 1063–1068.
20.
SpiraAPGamaldoAAAnY, et al.Self-reported sleep and β-amyloid deposition in community-dwelling older adults. JAMA Neurol2013; 70: 1537–1543.
21.
WinerJDetersKKennedyG, et al.Association of short and long sleep duration with amyloid-β burden and cognition in aging. JAMA Neurol2021; 78: 1187–1196.
22.
HuangXTHuangLYTanCC, et al.The role of APOE ε4 in modulating the relationship between non-genetic risk factors and dementia: a system review and meta-analysis. J Neurol2025; 272: 690.
23.
ZhangZXiaoXMaW, et al.Napping in older adults: a review of current literature. Curr Sleep Med Rep2020; 6: 129–135.
24.
GoldmanSEHallMBoudreauR, et al.Association between nighttime sleep and napping in older adults. Sleep2008; 31: 733–740.
25.
DeantoniMReytMBailletM, et al.Napping and circadian sleep–wake regulation during healthy aging. Sleep2023; 47: zsad287.
26.
ZhangHZhangLChenC, et al.Association between daytime napping and cognitive impairment among Chinese older population: a cross-sectional study. Environ Health Prev Med2023; 28: 72.
27.
LinJFLiFDChenXG, et al.Association of postlunch napping duration and night-time sleep duration with cognitive impairment in Chinese elderly: a cross-sectional study. BMJ Open2018; 8: e023188.
28.
KitamuraKWatanabeYNakamuraK, et al.Short daytime napping reduces the risk of cognitive decline in community-dwelling older adults: a 5-year longitudinal study. BMC Geriatr2021; 21: 474.
29.
LiPGaoLYuL, et al.Daytime napping and Alzheimer's dementia: a potential bidirectional relationship. Alzheimers Dement2023; 19: 158–168.
30.
AlqurashiYDAlHarkanKAldhawyanA, et al.Association between nap duration and cognitive functions among Saudi older adults. Front Neurosci2022; 16: 917987.
31.
CaiHSuNLiW, et al.Relationship between afternoon napping and cognitive function in the ageing Chinese population. Gen Psychiatr2021; 34: e100361.
32.
AsadaTMotonagaTYamagataZ, et al.Associations between retrospectively recalled napping behavior and later development of Alzheimer's disease: association with APOE genotypes. Sleep2000; 23: 629–634.
33.
PalpatzisEBassNJonesR, et al.Longitudinal association of apolipoprotein E and sleep with incident dementia. Alzheimers Dement2022; 18: 888–898.
34.
MutoVKoshmanovaEGhaemmaghamiP, et al.Alzheimer’s disease genetic risk and sleep phenotypes in healthy young men: association with more slow waves and daytime sleepiness. Sleep2020; 44: zsaa137.
35.
FoleyDJVitielloMVBliwiseDL, et al.Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the national sleep foundation ‘2003 sleep in America’ poll. Am J Geriatr Psychiatry2007; 15: 344–350.
36.
HalbisenALLuCY. Trends in availability of genetic tests in the United States, 2012-2022. J Pers Med2023; 13: 638.
37.
LuptonMKRobinsonGAAdamRJ, et al.A prospective cohort study of prodromal Alzheimer's disease: prospective imaging study of ageing: genes, brain and behaviour (PISA). Neuroimage Clin2021; 29: 102527.
38.
Cuellar-PartidaGSpringelkampHLucasSEM, et al.WNT10A Exonic variant increases the risk of keratoconus by decreasing corneal thickness. Hum Mol Genet2015; 24: 5060–5068.
39.
MedlandSENyholtDRPainterJN, et al.Common variants in the trichohyalin gene are associated with straight hair in europeans. Am J Hum Genet2009; 85: 750–755.
40.
McCarthySDasSKretzschmarW, et al.A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet2016; 48: 1279–1283.
41.
LuptonMKMedlandSEGordonSD, et al.Accuracy of inferred APOE genotypes for a range of genotyping arrays and imputation reference panels. J Alzheimers Dis2018; 64: 49–54.
42.
PurcellSNealeBTodd-BrownK, et al.PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet2007; 81: 559–575.
43.
BuysseDJReynoldsCFMonkTH, et al.The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res1989; 28: 193–213.
44.
GunzlerDDPerzynskiATCarleAC. Structural Equation Modeling for Health and Medicine. 1st ed.New York: Chapman and Hall/CRC, 2021.
45.
KaiserHF. The varimax criterion for analytic rotation in factor analysis. Psychometrika1958; 23: 187–200.
46.
SenaratnaCVPerretJLLodgeCJ, et al.Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev2017; 34: 70–81.
47.
BraleyTJDunietzGLChervinRD, et al.Recognition and diagnosis of obstructive sleep apnea in older Americans. J Am Geriatr Soc2018; 66: 1296–1302.
48.
ZokaeiNGiehlKSillenceA, et al.Sex and APOE: a memory advantage in male APOE ε4 carriers in midlife. cortex2017; 88: 98–105.
49.
ZokaeiNGroganJFallonSJ, et al.Short-term memory advantage for brief durations in human APOE ε4 carriers. Sci Rep2020; 10: 9503.
50.
BatureFGuinnBAPangD, et al.Signs and symptoms preceding the diagnosis of Alzheimer's disease: a systematic scoping review of literature from 1937 to 2016. BMJ Open2017; 7: e015746.
51.
AltmannAAksmanLMOxtobyNP, et al.Towards cascading genetic risk in Alzheimer’s disease. Brain2024; 147: 2680–2690.
52.
KumralDMatzerathALeonhartR, et al.Spindle-dependent memory consolidation in healthy adults: a meta-analysis. Neuropsychologia2023; 189: 108661.
53.
LafortuneMGagnonJFMartinN, et al.Sleep spindles and rapid eye movement sleep as predictors of next morning cognitive performance in healthy middle-aged and older participants. J Sleep Res2014; 23: 159–167.
54.
FernandezLMJLüthiA. Sleep spindles: mechanisms and functions. Physiol Rev2020; 100: 805–868.
55.
NaismithSLMowszowskiL. Sleep disturbance in mild cognitive impairment: a systematic review of recent findings. Curr Opin Psychiatry2018; 31: 153–159.
56.
AndréCMartineau-DussaultMBarilA, et al.REM Sleep is reduced in late middle-aged and older APOE4 allele carriers. Sleep2024; 47: zsae094.
57.
LiJCacchionePZHodgsonN, et al.Afternoon napping and cognition in Chinese older adults: findings from the China health and retirement longitudinal study baseline assessment. J Am Geriatr Soc2017; 65: 373–380.
